1-4 of 4
Yukiko Kitagawa, MD
Close
Sort by
Journal Articles

MLL-HOXA9 and Calcineurin Are Novel Therapeutic Targets in Multiple Myeloma

Yoichi Imai, MD, PhD, Eri Ohta, Yanhua Wang, MD, PhD, Yukiko Kitagawa, MD, PhD, Ye Ding, MD, PhD, Osamu Yamada, MD, PhD, Yoshiro Maru, MD, PhD, Toshiko Motoji, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 4007.
https://doi.org/10.1182/blood.V120.21.4007.4007
Published: 2012
Journal Articles

De-Regulation of MicroRNA Expression Is Detected in Hairy Cell Leukemia.

Yukiko Kitagawa, MD, PhD, Katia Basso, PhD, Manisha Brahmachary, PhD, Riccardo Dalla-Favera, Brunangelo Falini, MD
Journal: Blood
Blood (2009) 114 (22): 3462.
https://doi.org/10.1182/blood.V114.22.3462.3462
Published: 2009
Journal Articles

Histone Deacetylase Inhibitors Synergistically Enhance the Cytotoxic Effect of Hypomethylating Agents in Models of Diffuse Large B-Cell Lymphoma.

Matko Kalac, MD, Yukiko Kitagawa, MD, PhD, Seshan Ennapadam Venkatraman, Benjamin Tycko, MD, PhD, Owen A O'Connor, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 3720.
https://doi.org/10.1182/blood.V114.22.3720.3720
Published: 2009
Journal Articles

Investigating Mature B-Cell Lymphomas by MicroRNA Profiling.

Katia Basso, PhD, Pavel Morozov, PhD, Yukiko Kitagawa, MD, Roy L. Maute, Angelo Rosolen, MD, Chang-Zheng Chen, PhD, Andrea Califano, PhD, Riccardo Dalla-Favera, MD
Journal: Blood
Blood (2007) 110 (11): 3185.
https://doi.org/10.1182/blood.V110.11.3185.3185
Published: 2007